跳至主要内容
临床试验/ISRCTN10268258
ISRCTN10268258进行中(未招募)未知

Testing the effects of availability and ecolabels on the environmental impact of food purchases in worksite cafeterias: a randomised controlled trial

niversity of Oxford0 个研究点目标入组 90 人开始时间: 2022年1月6日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • UK-based worksite cafeterias that:
  • 1. Have electronic point-of-sale tills operated by the researchers' foodservice partner
  • 2. Are able to provide data at a detailed enough level to identify specific meals sold
  • 3. Have a minimum of 50 transactions/day at baseline

排除标准

  • Not offering main meal options

研究者

相似试验

已完成
不适用
Food labelling and online shopping study
ISRCTN15655434niversity of Oxford1,132
已完成
不适用
Eco-labels on Restaurant MenusNutritionFood SelectionFood PreferencesDietary HabitsHealthy Diet
NCT06584539Harvard Pilgrim Health Care3,147
已完成
不适用
Environmental Labelling in a Virtual SupermarketDiet, HealthyFood Selection
NCT04909372Centre des Sciences du Goût et de l'Alimentation133
已完成
不适用
The effect of reducing environmental stimuli on infant pain when inserting a central venous catheter
IRCT20200114046130N1Shahid Beheshti University of Medical Sciences60
进行中(未招募)
1 期
A phase I/ II study to assess the efficacy and safety of ABTL0812 in combination with paclitaxel and carboplatin in patients with advanced endometrial cancer or squamous NSCLCSquamous Cell Non-Small Cell Lung Cancerandadvanced endometrial cancerMedDRA version: 19.0Level: LLTClassification code 10014743Term: Endometrial carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10025120Term: Lung squamous cell carcinoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10071533Term: Lung squamous cell carcinoma metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10014747Term: Endometrial carcinoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10025124Term: Lung squamous cell carcinoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10014745Term: Endometrial carcinoma metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10014749Term: Endometrial carcinoma stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10014751Term: Endometrial carcinoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10025125Term: Lung squamous cell carcinoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10014750Term: Endometrial carc
EUCTR2016-001352-21-ESAbility Pharmaceuticals, S80